Drug of Indian Manufacturer Tentatively Approved by FDA

The FDA in the US has tentatively approved Aurobindo Pharma to manufacture and market levofloxacin tablets in the American market.

Levofloxacin tablets 250mg, 500mg, and 750mg. are prescribed for the treatment of bacterial infections like pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections in adults.

Bacterial Infections can be Tackled by Targeting a Specific Protein
A significant breakthrough has been made in fighting bacterial infections which can help scientists yield treatment measures for a number of infections, including antibiotic-resistant strains.

The company is waiting for the final approval before launching the product. It is also manufacturing facilities that are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, Anvisa Brazil.

Source-Medindia

Clinical Trials and Its different Phases
Clinical trials serve as a vital component for improving the treatment of medical conditions as they lead to higher standards of patient care.

Pneumonia - Causes, Symptoms, Diagnosis, Treatment, Prevention, Complications
Pneumonia is a lung infection that can be caused by a bacteria or a virus. It causes inflammation of the alveoli or the air sacs of the lungs.